MAPT and Alzheimer disease: Additionally, when comparing AD+sLATE– to AD+sLATE+, controlling for temporal Tau‐MaX at baseline, AD+sLATE+ displayed a significantly greater rate of atrophy, particularly within cortical MTL regions (Figure 2B IV).